首页> 外文期刊>The Indian journal of medical research. >Whole-body F-18-fluorodeoxyglucose positron emission tomography-computed tomography (F-18-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India
【24h】

Whole-body F-18-fluorodeoxyglucose positron emission tomography-computed tomography (F-18-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India

机译:全身F-18-氟脱氧氧基葡萄糖发射断层扫描 - 计算断层扫描(F-18-FDG PET / CT)用于分期局部晚期乳腺癌:印度南部第三次癌症中心的前瞻性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background & objectives: Locally advanced breast cancer (LABC) is associated with substantial risk of occult metastases. The patients with LABC have high rate of systemic relapse, suggesting inadequacy of the current conventional staging in detecting the occult metastatic spread. F-18-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) is a new modality in the staging of breast cancer patients. Hence, this study was conducted to evaluate the role of F-18-FDG PET/CT in initial staging of LABC and to compare it with conventional methods.
机译:背景和目标:局部晚期的乳腺癌(Labc)与隐匿性转移的大量风险有关。 Labc患者具有高度的全身复发率,这表明目前常规分期的不足以检测隐匿性转移扩散。 F-18-氟脱氧氧(FDG)正电子发射断层摄影 - 计算断层扫描(PET / CT)是乳腺癌患者分期中的一种新型。 因此,进行该研究以评估F-18-FDG PET / CT在Labc的初始分期中的作用,并与常规方法进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号